Form 4: Bioventus Inc. SVP & CFO Sells Shares to Cover Taxes After Vesting

Bioventus Inc.'s SVP & CFO, Mark Leonard Singleton, sold 10,733 shares of Class A Common Stock to cover taxes after restricted stock units vested.

Summary

• Mark Leonard Singleton, the SVP & CFO of Bioventus Inc., sold 10,733 shares of Class A Common Stock on December 23, 2024.
• The sale was executed to cover taxes associated with the vesting of restricted stock units on December 20, 2024.
• The shares were sold at a weighted average price of $10.53, with individual transactions ranging from $10.41 to $10.71.
• The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on June 20, 2023.
• Following the transaction, Mr. Singleton directly owns 105,162 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: This is a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any new material non-public information.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a common practice among publicly traded companies to allow insiders to sell shares without concerns about insider trading violations.
• The sale of shares to cover taxes upon vesting of restricted stock units is a standard practice for executives in many companies, including those in the medical device industry such as Stryker and Medtronic.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

Bioventus Inc., insider trading, Form 4, stock sale, executive compensation, 10b5-1 plan, BVS, Mark Leonard Singleton, restricted stock units